QuidelOrtho
Search results
Ortho Clinical Diagnostics; Solutions Chemistry and Immunodiagnostics Transfusion Medicine Portfolio Overview Automation XT Solutions COVID-19 Testing Solutions Informatics QC Solutions Integration Product Portfolio Full Automation Semi Automation Data/Workflow Menu Products Chemistry and Immunodiagnostics Transfusion Medicine Support Integrated Products VITROS XT 7600 VITROS 5600 Chemistry VITROS XT 3400 VITROS 4600 Immunoassay VITROS 3600
Clinical chemistry & immunoassay. ... Molecular diagnostics platforms. Controls & supplies. Products. Find best-in-class solutions that span the entire healthcare continuum – from home to hospital, lab to clinic. Copan Lab Supplies. ... Ortho Vision ® Swift Automated Immunohematology System. Ortho ...
Home Page
Ortho Clinical Diagnostics. 89,344 followers. 1y. We’ve become QuidelOrtho, continuing our more than 80-year legacy of taking diagnostics to the next level. United as one, we'll continue to ...
Ortho Clinical Diagnostics; Solutions Improve Lab Performance Maximize staff productivity and system performance while reducing errors. Achieve Cost Management Lower costs with accurate financial tracking across your lab. Enhance Clinical Outcomes Deliver accuracy and consistency of results to enhance patient care. Overcome Staffing Challenges Make more efficient use of staff's time to attract and retain it.
Point-of-care testing solutions from Ortho Clinical Diagnostics, a global leader in in vitro diagnostics. Learn more about our products and services.
Ortho Clinical Diagnostics (now QuidelOrtho) was an in vitro diagnostics company that made products and diagnostic equipment for blood testing. Ortho served two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology ...
Dec 23, 2021 · SAN DIEGO & RARITAN, N.J.--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies, for $24.68 per share of common stock using a combination of cash and newly issued shares in the combined company, representing a 25% premium over Ortho’s closing ...
Ortho Clinical Diagnostics Holdings is a company that provides in vitro diagnostics solutions to clinical laboratories and immunohematology communities. It offers chemistry and immunodiagnostics solutions, including integrated chemistry systems, immunodiagnostic systems, laboratory automation, and middleware solutions, and acute kidney injury-acute renal failure testing devices and meters. The company also provides transfusion medicine solutions such as immunohematology analyzers ...
By powerfully informing clinical decisions, VITROS ® B•R•A•H•M•S PCT brings clarity to both diagnosis and treatment assessment, promoting potential:
